Dallas Tx 10/15/2009 1:23:09 AM
News / Business

MFLI, AMNP, MDOR, BMGP, SLAT, SNDY, SGAS, PDMI, GSAE, MYNG, VIAP OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, October 14th

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

Our Stocks to Watch today include Muscle Flex Inc. (OTC: MFLI), American Sierra Gold Corp. (OTCBB: AMNP), Magnum D'Or Resources Inc. (OTCBB: MDOR), Biomagnetics Diagnostics Corp. (OTC: BMGP), Superlattice Power Inc. (OTCBB: SLAT), Solos Endoscopy Inc. (OTC: SNDY), Sino Gas International Holdings Inc. (OTCBB: SGAS), Paradigm Medical Industries Inc. (OTCBB: PDMI), Green Star Alternative Energy Inc. (OTC: GSAE), Golden Eagle International Inc. (OTCBB: MYNG) and VIA Pharmaceuticals Inc. (Nasdaq: VIAP).

 

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

 

MUSCLE FLEX INCORPORATED (OTC: MFLI)

 

Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php 

 

Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm

 

Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.

 

MFLI News:

 

October 14 - Muscle Flex Prepares for the November National Launch of The BUDDY Tablet Caddy and The Beagle StepFit Pedometer Infomercials and Provides Detail on Its Marketing Strategy

 

Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlexInc.com) announced that it is preparing for the November national launch of the The BUDDY Tablet Caddy™ (www.BUDDYTabletCaddy.com) and The Beagle StepFit™ Pedometer infomercials (www.BeagleStepFit.com). Muscle Flex will be launching both products simultaneously with each product being featured in their own 2-minute infomercial. The Muscle Flex strategy is to open up markets for each of its products through a multi-faceted marketing approach. This includes:

 

1. Airing and releasing The BUDDY and The Beagle in the same markets to intentionally increase the repetitive effects of the TV exposure.

 

2. Cross pollinating and up-selling The BUDDY with the The Beagle, and vice versa, by offering the other through an up-sell to the consumer with an applied discount (20% - 25%) both through the online e-commerce engine and live operator sales.

 

3. A dedicated one-page landing page for each product.

 

4. Reinforce each local market with print media; primarily newspaper and direct mail pieces.

 

5. Online Guerilla marketing tactics.

 

6. "Pay per performance" TV media as well as TV media purchase.

 

Muscle Flex strongly believes in "brand visibility & recognition" as it develops each market, which is why releasing multiple products in the same markets is a key element in maximizing the revenue potential of each product campaign and allowing Muscle Flex to release subsequent products in markets in which it has established brand identity and recognition.

 

The Muscle Flex strategy is a "Drive to the Internet" strategy where transaction costs are the most advantageous; however, a 1-800 customer order feature is always included on all product releases. Each respective one-page landing ecommerce page for the BUDDY and The Beagle is currently being finalized.

 

Muscle Flex has a number of additional products that are ready for commercial distribution which include an at-home water filtration product it expects to retail from between $19.95 - $29.95, the Muscle Flex VATA Brasil™ Sports and Active Wear Collection and several other products that Muscle Flex will provide additional details on shortly. Muscle Flex is focusing its time and resources in the lower priced item categories which requires a fraction of the resources to bring a product to market and dramatically mitigates risk by spreading its resources across a number of consumer products as opposed to one large high priced item. As well, 2-minute short form commercials allow for 24 hour / 7 day penetration into national cable and network markets as opposed to the 30-minute format which is limited in the time and day it can air. This allows Muscle Flex to grow its brand(s) and consumer awareness across a wider audience from both a demographic and geographic perspective.

 

AMERICAN SIERRA GOLD CORPORATION (OTCBB: AMNP)

 

Detailed Quote: http://www.otcpicks.com/quotes/AMNP.php 

 

Company Profile: http://www.otcpicks.com/american-sierra-gold/american-sierra-gold.htm

 

American Sierra Gold Corp. is a publicly traded independent gold exploration company headquartered in Reno, Nevada. Shareholders and prospective investors are encouraged to call investor relations at 1-888-279-3921 or visit American Sierra Gold Corp's website at www.americansierragold.com.

 

AMNP News:

 

October 14 - Emerging Stock Report Initiates Independent Research Coverage On American Sierra Gold Corp.

 

Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on American Sierra Gold Corp. (OTCBB: AMNP). Emerging Stock Report is currently offering a complimentary trial subscription. View the company's research at www.emergingstockreport.com.

 

October 13 - American Sierra Gold Corp. Signs $6 Million Equity Financing Agreement

 

American Sierra Gold Corp. (OTCBB: AMNP), an independent gold exploration company headquartered in Reno, Nevada, announced that it has entered into an equity financing agreement with a European-based institutional investor for up to $6,000,000.

 

"We are very pleased to have closed this equity financing agreement as it will allow us to fund the implementation of our operations and acquisitions strategy. This agreement is an indication of confidence in the future of our projects and will ensure the future growth of the Company," stated Mr. Wayne Gruden, American Sierra Gold's CEO and President. "The stock purchase warrants attached to each unit to be sold under this agreement, could eventually translate into an additional $10.5 million in funding available to the company," added Mr. Gruden.

 

Under the terms of the agreement, American Sierra has the right to call upon funds for up to $6,000,000 by issuing units consisting of one share of its common stock and one common stock purchase warrant exercisable for the purchase of one additional share of common stock. The securities to be issued under the agreement have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent a registration or an applicable exemption from the registration requirements. Full details of this agreement can be reviewed on our latest SEC filings.

 

MAGNUM D'OR RESOURCES (OTCBB: MDOR)

 

Detailed Quote: http://www.otcpicks.com/quotes/MDOR.php 

 

Company Profile: http://www.otcpicks.com/magnum-resources/magnum-resources.htm

 

Magnum d'Or Resources, Inc. focuses in operating in recycling and waste management sectors. It intends to develop facilities that produce rubber powders, thermoplastics, and thermoplastics elastomers. Magnum holds licensing rights to various patents that would allow rubber to be devulcanized, specialty blend EPDM powders, and EPDM compounds. The company was founded in 1999 and is based in Ft. Lauderdale, Florida.

 

MDOR News:

 

October 14 - Greentech International Advisors Returns From Successful International Conference and Updates the Market

 

Greentech International Advisors, Inc announces breakthrough developments with Magnum D'Or Resources, Inc. (OTCBB: MDOR) , a next generation rubber recycling solutions company.

 

Greentech would like to announce the following important information:

 

First, the official test results from the RRI World Renowned (Malaysia Rubber Research Institute facility in Sungai Buloh www.lgm.gov.my) are available and will be released in detail this week.

 

Second, that positive major news is expected to be released by the week of the 19th of October 2009, with regards to the Colorado site.

 

Third, Magnum is expected to receive independent national and international media coverage within the next couple of weeks.

 

Further, Greentech's V.P. stated, "I just returned from successful international conference involving the marketing and exposure of Magnum's Revolutionary technology and Rubber Recycling processes. I am thrilled to say that there are some good times ahead of us and that over the last few weeks MDOR has released astounding news that shows that Magnum and the Magnum/SRI Force are positioned to become a Market Leader in the Global Rubber Production Market."

 

Greentech is confident that MDOR is a solid investment opportunity for the following reasons:

 

First, MDOR has developed a number of Magnum/SRI custom compounds to be used in several challenging and commercially important applications. Their efforts have targeted applications ranging from general molded and extruded rubber goods through more demanding applications, such as premium retread and medium specification automotive components.

 

Second, they have also put a great deal of effort in successfully producing a Magnum/SRI custom compound to be used as a substantive component in light truck tire manufacture. This in itself was a Worldwide Breakthrough and a First in the History of the Rubber Industry and MDOR achieved it successfully.

 

Third, MDOR can successfully activate crumb rubber produced at their facilities and then process it into a custom compound that can be used as a substantial substitution component in the manufacture of OEM light truck tires without compromise in properties. Prior to recent Magnum/SRI positive test results, this had never been accomplished at these levels before and the challenges in achieving it had been more then substantial.

 

Greentech's certain that MDOR is a major opportunity at these levels for the following reasons:

 

First, up until recent successful Magnum news, it should be noted that in technically challenging compound applications, such as OEM tires, the proportion of recycled content has historically been limited to a very small proportion if any. Usually the amount of surface treated tire crumb utilized in these applications is limited to only 2% to 3% (max) range. Any lager amount tends to lead to very serious and unacceptable consequences in terms of performance parameters and even catastrophic failure. Since people's lives are dependent upon performance parameters in this category they are not taken lightly. Even in the case of Retread compounds the level of recycled content and usage of processing aids is limited. This translates directly to the quality and performance of the retread.

 

Prior to the recent Breakthrough Success of Magnum/SRI there had been NO material, process, or technology to date that has been able to successfully break into this category which covers automotive to heavy truck tires. However Magnum/SRI have officially made history with their Revolutionary Custom Compounds by adding 20% rubber recycled content to an EOM Light Truck Tire and still had it produce the same value added performance and properties as the Original Virgin Light Truck OEM Tire.

 

Second, as recently stated Magnum Engineering International (MEI) is in serious negotiations to close on several new projects that are expected to generate a gross sale in excess of $40,000,000 US and are expected to be finalized by January 2010. We feel the recent news announcement will help add a substantial amount of revenue and earnings to the company's bottom-line as well as propelling the company forward in the next few months which could lead to a much stronger stock and company (liquidity too).

 

Third, there are several major accomplishments including facts and data, that proves why MDOR will leapfrog into the future for OEM Virgin Tire and Retread tire manufactures. These two markets alone are roughly a $20 billion industry that MDOR has successfully entered with their Breakthrough Revolutionary Magnum/SRI custom compounds. Magnum/SRI Revolutionary custom compounds will not only provide the value added properties but also provide the manufacture (client) with substantial cost savings on their raw material purchases."

 

October 13 - Magnum Engineering International ('MEI') Announces $40 Million in Expected Projects

 

Magnum D'Or Resources, Inc. (OTCBB: MDOR), a next generation rubber recycling Solutions Company, wholly owned subsidiary, Magnum Engineering International, Inc. ('MEI')

 

MEI is aggressively entering the environmental solutions market with proven technology to design and construct turnkey plants, as well as provide complete environmental solutions to third parties utilizing profitable business models. Part of that mission is to assure quality, excellence and continual improvement of environmental performance. One of MEI's staff engineers stated, "We have developed a model that allows us to build plants for clients around the world, have them financed using export financing, and arrange for the sale of the output through Magnum's network of clients. Furthermore, the business model establishes a rapid investor payback within 36 months."

 

MEI Recent Negotiations

 

MEI is in both initial and final negotiations with a number of parties and is working with U.S. government affiliates in order to conclude the anticipated ventures. The current projects are expected to generate a gross sale in excess of $40,000,000 US and are expected to be finalized by January 2010. MEI is excited to announce their current negotiations involve several large institutions in order to build full service facilities in both the Middle East and Europe.

 

Glusic went on to say, "There has been a tremendous amount of discussions, both national and international, with companies looking for assistance for solutions to their tire and rubber recycling issues."

 

President and CEO of Magnum, Joseph Glusic commented, "I am extremely pleased at how quickly MEI has developed the market we had previously ignored. This will prove to be a profit center of its own, adding directly to the bottom line of Magnum. Although we knew there was considerable interest in our process and technology we never really took the opportunity to focus on that market. Now we have the personnel and the resources to support these activities."

 

In addition to assisting the Magnum group with all technical and engineering solution services, MEI has recently assumed all client inquires, discussions, and International negotiations that were previously being conducted by MDOR in relation to third party recycling solutions. MEI and its affiliates are developing a full service engineering and service solutions company.

 

MEI Strategic Plans

 

MDOR has recently received the initial equipment necessary to commence work on the Colorado site. MEI has officially commenced work on developing a turnkey state of the art rubber recycling plant in Colorado using some of the most advanced technology available on the market. MEI and Magnum/SRI have been working hand and hand to determine the most economical and beneficial solution for the fine rubber production output. MDOR plans to produce large quantities of high end/high quality rubber powders, as well as, revolutionary custom compounds at the site. MEI has already taken steps in order to launch the new look for Magnum's Magog facility for the production of high quality fine rubber powders. These powders will be immediately introduced to the Magnum/SRI Next Generation Custom Compounds in the near term.

 

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

 

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php 

 

Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm

 

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

 

BMGP News:

 

October 14 - New Technology Hopes to Change Field Diagnostic Testing as We Know It

 

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has released an exclusive interview with a spokesman for Biomagnetics Diagnostics Corp. (OTC: BMGP), the company behind a revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis field testing.

 

Several key developments have put this company on biotech investors' radar screens in recent weeks and according to one report, the low-float penny stock that is still trading well below analyst estimates.

 

Diagnostics, the technologies and tools used to identify diseases and conditions in patients, make up the second-largest portion of the biotechnology industry, and this technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test and is designed to detect the actual virus and viral load in any body fluid. Learn more about the company's goals to provide this innovative technology, which was originally developed by the U.S. Department of Homeland Security, via the special report interview which is available now at BioMedReports.com:

 

http://biomedreports.com/articles/most-popular/12852-diagnostics-company-aims-to-change-lab-field-testing-otcbmgp.html

 

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

 

http://biomedreports.com/fda-calendar/fda-calendar.html

 

October 13 - Biomagnetics Diagnostics Corp. Subject of Cover Page Story in Prestigious BioMedReports Electronic Newsletter

 

Biomagnetics Diagnostics Corp. (OTC: BMGP), a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV, and hepatitis testing, today announced the Company is the subject of a cover page story in the prestigious BioMedReports electronic newsletter and portal. BioMedReports covers medical news and the healthcare financial sector. The cover page story and associated audio interview can be viewed at:

 

http://biomedreports.com/articles/most-popular/12852-diagnostics-company-aims-to-change-lab-field-testing-otcbmgp.html.

 

“The information contained in the BioMedReports article and interview provides an excellent overview of our strategic and product directions. We are very excited about our entrance into the integrated optical biosensor market, especially relating to the malaria and bovine tuberculosis testing market,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics Corp. “We believe significant demand currently exists within this underserved market and we expect the size of the market opportunity to continue to expand over the coming years.”

 

According to the World Health Organization, some 3.2 billion people, or about half the world's population, is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. Early detection substantially improves treatability and survivability. Field deployable integrated optical biosensor systems, such as those under development at Biomagnetics Diagnostics, hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs.

 

SUPERLATTICE POWER INCORPORATED (OTCBB: SLAT)

"Up 3.13% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SLAT.php 

 

Company Profile: http://www.otcpicks.com/superlattice-power.htm

 

Superlattice Power, Inc. was incorporated in Nevada in 2004 and is a development stage technology company that is focusing its resources and efforts on the development and marketing of lithium-powered vehicles and products, as well as on commercial and residential properties. Everything from scooters, bicycles, mopeds, motorcycles, cars and homes are being converted successfully to zero-emission, lithium-powered vehicles and facilities.

 

SLAT News:

 

October 13 - Superlattice Power, Inc. 3-for-1 Forward Stock Split Record Date to be Effective Shortly On Date to be Approved by FINRA

 

Superlattice Power, Inc. (OTCBB: SLAT) (www.superlatticepower.com), emerging leader in the development and marketing of next generation lithium-powered batteries worldwide, announced that its three-for-one forward stock split will be effective shortly upon completion of the review process by the Financial Industry Regulatory Authority (FINRA). The Company is submitting additional information to FINRA to complete its submission of required information in connection with FINRA's review process.

 

SOLOS ENDOSCOPY INCORPORATED (OTC: SNDY)

"Up 119.48% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SNDY.php

 

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.

 

SNDY News:

 

October 14 - Solos Endoscopy, Inc.'s FDA Approved MammoView™ Product Line to Obtain CE Mark

 

Company to Enter the $94 Billion European Medical Device Market

 

Solos Endoscopy, Inc. (OTC: SNDY) announced that the Company has taken the initial steps to obtain the CE Mark for its Food and Drug Administration (FDA) approved MammoView™ line of surgical endoscopy instruments. This will allow the MammoView™ line to be sold throughout the European Economic Union (EEU). The entire Solos Endoscopy product line has already received FDA approval for sale within the U.S. and the Company is now working diligently to capture market share within the EEU. According to a 2009 report published by Frost & Sullivan, the EEU represents $94 Billion, or 30%, of the worldwide demand for medical instruments.

 

Solos Endoscopy is working closely with its manufacturers to ensure all requirements of the Medical Devices Directive (MDD 93/42/EEC) are met. The Company is familiar with the steps that are to be taken to obtain the CE Mark for its MammoView™ line of surgical endoscopy instruments, as all of the Company's other medical devices have already obtained the CE Mark. Solos Endoscopy is currently in discussions with several companies, to act as its Authorized Representatives (EC REP) to liaison with its targeted European markets.

 

"Expanding into the EEU provides unlimited sales opportunities for Solos Endoscopy and our goal is to commence sales, within several European countries, in 2010," stated Bob Segersten, President of Solos Endoscopy, Inc.

 

SINO GAS INTERNATIONAL HOLDINGS (OTCBB: SGAS)

"Up 31.15% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SGAS.php

 

The Company, through its indirectly wholly-owned subsidiary, Beijing Zhong Ran Wei Ye Gas Co., Ltd. ("Beijing Gas"), and the subsidiaries of Beijing Gas, is a leading developer of natural gas distribution systems in small and medium size cities in China, as well as a distributor of natural gas to residential, commercial and industrial customers in China. The company owns and operates 37 natural gas distribution systems serving approximately 100,900 residential and five commercial and industrial customers. Facilities include approximately 710 kilometers of pipeline and delivery networks with a daily capacity of approximately 89,000 cubic meters of natural gas. The Company owns and operates natural gas distribution systems in Beijing, Hebei, Jilin, Jiangsu and Anhui Provinces.

 

SGAS News:

 

August 13 - Sino Gas International Holdings, Inc.'s 2nd Quarter of 2009 Earnings Conference Call

 

Sino Gas International Holdings, Inc. (OTCBB: SGAS) ("Sino Gas" or the "Company") announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Wednesday, Aug 19, 2009 to discuss the second quarter of 2009 financial results.

 

Joining Mr. Yu-chuan Liu, President and Chief Executive Officer of Sino Gas, will be Mr. Yugang Zhang, Chief Financial Officer, and Ms. Chunying Chai, IR Officer.

 

Prior to the conference call, the Company plans to release its second quarter 2009 financial results on Wednesday, Aug 19, 2009.

 

To participate in the live conference call, please dial the following number: 800 688 0796 or 617 614.4070 for International callers, access Code 561 544 19.

 

If you are unable to participate in the call at this time, a 14-day replay will be available from 9:45 a.m. Aug 19, 2009. To access the replay, dial 888-286-8010 or 617-801-6888 for international callers, access Code 79770728.

 

PARADIGM MEDICAL INDUSTRIES INCORPORATED (OTCBB: PDMI)

"Up 40.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/PDMI.php 

 

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

 

PDMI News:

 

June 1 - Paradigm Medical Announces Plans to Release Its New Corneal Topographer, the Paravue, in the United States Market

 

Paradigm Medical Industries, Inc. (OTCBB: PDMI) announced that the Company will soon begin to introduce the first of its four new ophthalmic diagnostic devices, the Paravue, during the remainder of 2009. The Paravue is a sophisticated topographer utilizing Placido Disk Technology and an advanced software to provide accurate and detailed analysis of the anterior corneal surface.

 

Corneal topography — also known as videokeratography or corneal mapping — represents a significant advance in the measurement of the corneal curvature. Most corneal topographers evaluate 8,000 to 10,000 specific points across the entire corneal surface. By contrast, the Paravue processes more than 100,000 points. It also offers corneal wave front analysis with 2, 3 or 4 maps available for comparison.

 

The Paravue provides both a qualitative and quantitative evaluation of corneal curvature. It does so by utilizing a big placido disk with 24 concentric rings, which project onto the cornea to create a virtual image. The device compares this image to the target size, and the computer then calculates the corneal curvature. Advanced features including advanced rings editing, variable scales, refractive power map and more make the Paravue a valuable tool in the optometric and ophthalmic clinics.

 

"The addition of the Paravue to our existing ophthalmic product line fills an important segment that was missing," said Paradigm Medical President, Stephen Davis. "We are excited to offer not just another topographer, but one with many impressive features and incredibly friendly software that provides ease of use, flexible mapping and accuracy."

 

GREEN STAR ALTERNATIVE ENERGY INCORPORATED (OTC: GSAE)

"Up 21.37% in morning trading"

 

Detailed Quote: www.otcpicks.com/quotes/GSAE.php 

 

Green Star Alternative Energy is an environmentally conscious, renewable energy producer. The Company is working to develop more than 300 MW (megawatts) of clean electricity through wind energy. The corporate revenue model is two-fold: the use of a renewable resource allows not only for the creation of environmentally friendly energy, but the granting of carbon (greenhouse gas) emission credits which may be traded and sold. Green Star is pursuing a significant opportunity to provide clean energy to the growing Republic of Serbia and neighbouring European countries. Through a joint venture with key wind farm and power trading company Notos, Green Star will become the nation's first developer of wind power. GSAE is focussed on green technology and sustainable energy programs like wind turbines, hydro electric power generation, and other renewable electricity models.

 

GSAE News:

 

October 13 - Green Star Agrees to Terms on 120MW Wind Farm Development

 

Green Star Alternative Energy, Inc. (OTC: GSAE) (“GSAE” or the “Company”) announced that an agreement to develop a 120 MW wind farm has been reached with Wellbury Infrastrukturberatungsgesellschaft GmbH.

 

A corporate structure is being created for this endeavour in a new Serbian subsidiary company, whose ownership will be maintained by both Green Star and Wellbury. The terms of the agreement include a joint 50-50 title, with complete recoupment of all expenditures by Green Star before any division of profits.

 

This advanced stage project is to be sited in North East Serbia – specifically in the Municipality of Pancevo, District of Banat, within the Autonomous Province of Vojvodina. Over 28 months of wind resource data has been accumulated over three micro locations and the results indicate a significant energy potential of 120 MW. A “Protocol of Cooperation” has been signed by the City of Pancevo, Secretariat of Energy for AP Vojvodina, and the Serbian Energy Efficiency Agency; and a license for grid connection is in process by the national transmission operator (EMS).

 

Dr. Miodrag Obradovic, CEO of Wellbury Infrastrukturberatungsgesellschaft GmbH, commented: “An alliance with Green Star Alternative Energy is a perfect fit for Wellbury. Green Star is dynamic team with an impressive vision for this burgeoning wind energy industry in Serbia.”

 

GOLDEN EAGLE INTERNATIONAL (OTCBB: MYNG)

"Up 17.24% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/MYNG.php

 

Golden Eagle International, Inc. is a gold and copper exploration, mining and milling company headquartered in Salt Lake City, Utah; with offices in Elko, Nevada and Santa Cruz, Bolivia. The Company's most recent efforts have centered on its Agreement with Queenstake Resources USA, Inc. for the maintenance and ongoing regulatory compliance of the Jerritt Canyon 4,000 tpd CIL gold mill. In addition, Golden Eagle is working to maximize the potential of its Gold Bar 4,000 tpd CIP gold mill located in Eureka, Nevada through a joint venture, toll refining arrangement or potential merger. The Company has temporarily suspended operations at its C Zone gold mine and mill within its 136,500 acres (213 square miles) in eastern Bolivia's Precambrian Shield. Golden Eagle has also temporarily suspended its continuing development of its Buen Futuro A Zone gold and copper project in eastern Bolivia.

 

MYNG News:

 

October 13 - Golden Eagle Receives Letter of Intent Offering $10 Million for the Purchase of Gold Bar Mill and Invitation to Negotiate Operating Agreement

 

Golden Eagle International, Inc. (OTCBB: MYNG) reported that it has received a Letter of Intent ("LOI") offering $10 million for the purchase of the Company's Gold Bar mill from LWMG, LLC ("LWMG"), a private exploration and mining company with mining interests in Nevada and Utah. The Gold Bar mill is a 3,500 to 4,000 tpd CIP gold mill located 25 miles northwest of Eureka, Nevada that Golden Eagle has owned since 2004.

 

The terms of the LOI provide for a $1 million down payment to be made by October 30, 2009, with $9 million deposited into escrow pending the completion of the permitting process. LWMG has also offered to negotiate a long-term operating agreement (referred to as a "tolling relationship" in its LOI), which would call for Golden Eagle to be the operator of the Gold Bar mill. However, if the permitting process were not successful, then the offered purchase price would decline to $5 million.

 

The Company anticipates that it an LWMG will meet in the near future to negotiate the terms and conditions of both the proposed sale of the Gold Bar mill and the operating agreement. Golden Eagle also intends to carry out due diligence regarding LWMG's offer, and further intends to cooperate with LWMG on its due diligence with respect to the proposed transaction. Among the questions to be addressed during the negotiation period are when the $1 million down payment will be made and the conditions for its return to LWMG, when the $9 million will be deposited into escrow, the nature of the permitting that will be required as a condition for the full $10 million purchase price, to allocate responsibility for permitting and due diligence operations, to set forth additional conditions precedent to the transaction, and to establish a timetable for the completion of the transaction.

 

While Golden Eagle cannot offer any assurance that it will reach satisfactory terms with LWMG regarding its offer to purchase the Gold Bar mill, or for an operating agreement, the Company intends to enter into good faith negotiations with LWMG to seek mutually beneficial terms and conditions.

 

VIA PHARMACEUTICALS INCORPORATED (NASDAQ: VIAP)

"Up 24.75% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/VIAP.php

 

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and inflammation.

 

VIAP News:

 

October 13 - VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ

 

VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on October 9, 2009, it received a determination letter from The NASDAQ Stock Market ("NASDAQ") notifying the Company that the NASDAQ Hearing Panel (the "Panel") has granted the Company's request to remain listed on NASDAQ, subject to the Company demonstrating compliance with the NASDAQ Listing Rules (the "Listing Rules") on or before December 31, 2009 (the "Exception Period"). During the Exception Period, the Company must provide prompt notification of any significant events to NASDAQ.

 

The Panel granted the Company's request after a hearing held on August 27, 2009 in which the Company presented its plan of compliance (the "Plan") with respect to its failure to satisfy NASDAQ's minimum $2.5 million stockholders' equity, board independence, and $1.00 minimum bid price requirements for continued listing. Based on the Company's Plan and its continued execution of the Plan, the Panel found that it was appropriate to allow the Company to remain listed on NASDAQ while the Company works to regain compliance with the Listing Rules.

 

There can be no assurance that the Company will be able to achieve or sustain the requirements under the Listing Rules to insure that it will maintain its NASDAQ listing.

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.

Disclosure: OTCPicks.com has been compensated three thousand five hundred dollars from Dana Alex for MFLI advertising and promotional services. OTCPicks has been compensated seven thousand five hundred dollars from a non-controlling third party (BlueWave Advisors) for AMNP advertising and promotional services. OTCPicks has been compensated ten thousand dollars from a non-controlling third party (GREEN TECH INTERNATIONAL ADVISORS) for MDOR advertising and promotional services. OTCPicks.com has been compensated seven thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has been compensated ten thousand dollars by the company for a current BMGP advertising and promotional services. OTCPicks.com has been previously compensated five thousand dollars by a third party (Blue Wave Advisors) for SLAT advertising and promotional services. OTCPicks.com has been recently compensated two thousand five hundred dollars by a third party (Blue Wave Advisors) for the current SLAT advertising and promotional campaign. OTCPicks.com has been compensated one million free trading shares by a non-controlling third party for PDMI advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by the company for GSAE advertising and promotional services. OTCPicks.com has recently been compensated five thousand free trading shares from Onyx Consulting for GSAE advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.